Max Robotics — Global Service Robot Directory + US Certification

About

Viola Salvestrini is a leading radiation oncologist whose research centers on innovative radiotherapy techniques for breast cancer, with a particular focus on preoperative partial breast irradiation and stereotactic radiosurgery. Her most impactful work stems from the phase II ROCK trial (NCT03520894), which investigated preoperative robotic radiosurgery for early breast cancer. This landmark study, published in 2022 and cited 29 times, demonstrated the feasibility and safety of treating a well-defined tumor target before surgery—a paradigm-shifting approach that could reduce treatment volumes and improve cosmetic outcomes. Salvestrini’s contributions have helped advance the field of partial breast irradiation by refining patient selection and treatment protocols, offering a less invasive alternative to whole-breast radiation. Her research bridges the gap between surgical oncology and radiation therapy, with potential to shorten treatment courses and minimize toxicity. With a growing citation impact, Salvestrini is recognized for her role in translating cutting-edge technology into clinical practice, and her work continues to influence guidelines for early-stage breast cancer management.